The Competition Commission of India (CCI) conducted a thorough investigation into a merger of equals between the Dow Chemical Company and DuPont (EI du Pont de Nemours & Company) to form DowDuPont with a combined market capitalization of around US$130 billion.
“The aggregate value of worldwide assets as well as turnover of Dow and DuPont, and the aggregate value of assets as well as turnover in India exceeded the jurisdictional thresholds in India,” said Shiraz Patodia, a partner at Dua Associates, which was the India antitrust counsel for Dow. “Therefore, clearance from the CCI had to be obtained in relation to the said transaction.”
Patodia said the transaction fell within the definition of a “combination” under section 5(a) of the Competition Act, 2002. The products manufactured/sold by Dow and DuPont in India were found to be overlapping in the broader segments of agriculture, specialty chemicals and materials sciences.
You must be a
subscribersubscribersubscribersubscriber
to read this content, please
subscribesubscribesubscribesubscribe
today.
For group subscribers, please click here to access.
Interested in group subscription? Please contact us.
你需要登录去解锁本文内容。欢迎注册账号。如果想阅读月刊所有文章，欢迎成为我们的订阅会员成为我们的订阅会员。
